Innovative pan-tumor target strategy for CAR-T therapy: cancer-specific exons as novel targets for pediatric solid and brain tumors
Abstract Chimeric antigen receptor T-cell (CAR-T) immunotherapy has achieved remarkable success in treating chemotherapy-refractory hematological malignancies. However, its efficacy in solid and brain tumors remains limited due to challenges such as insufficient target antigens, poor T-cell adaptabi...
Saved in:
| Main Authors: | Yuqing Luo, Jianqiao Shentu, Hening Xu, Yongming Xia, Lili Fang, Shiwei Duan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-024-05861-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-armored-cell therapy in solid tumor treatment
by: Yan Liu, et al.
Published: (2024-11-01) -
Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors
by: Nastaran Khazamipour, et al.
Published: (2024-10-01) -
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
by: Safwaan H. Khan, et al.
Published: (2025-01-01) -
MDSC: a new potential breakthrough in CAR-T therapy for solid tumors
by: Nada Mohamady Farouk Abdalsalam, et al.
Published: (2024-12-01) -
Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy
by: Yekai Feng, et al.
Published: (2024-11-01)